Dishman Carbogen Amcis · NSE: DCAL · BSE: 540701
Q4 FY25 results · Jan–Mar 2025
Dishman Carbogen Amcis reported revenue from operations of ₹716.34 crore (up 9.4% from Q4 FY24) and net profit of ₹43.09 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 716.34 | 654.71 | +9.4% | 682.34 | +5.0% |
| Other income | 7.97 | 7.16 | +11.3% | 5.63 | +41.6% |
| Total income | 724.31 | 661.87 | +9.4% | 687.97 | +5.3% |
| Profit before tax | 27.70 | (49.20) | Turned profit | 27.05 | +2.4% |
| Net profit for the period | 43.09 | (69.92) | Turned profit | 4.63 | +830.7% |
| EPS, basic (₹) | 2.75 | (4.46) | Turned profit | 0.30 | +816.7% |
| Net margin (%) | 6.0 | -10.7 | 0.7 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 106.10 | 111.26 | −4.6% | 97.04 | +9.3% |
| Other income | 5.47 | (3.21) | Turned profit | (8.01) | Turned profit |
| Total income | 111.57 | 108.05 | +3.3% | 89.03 | +25.3% |
| Profit before tax | (11.41) | (33.63) | Loss narrowed | (19.30) | Loss narrowed |
| Net profit for the period | (7.37) | (31.12) | Loss narrowed | (13.28) | Loss narrowed |
| EPS, basic (₹) | (0.47) | (1.98) | Loss narrowed | (0.85) | Loss narrowed |
| Net margin (%) | -6.9 | -28.0 | -13.7 |
Consolidated
- Filed with BSE
- 22 May 2025, 12:51 IST
- Board meeting
- 21 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 22 May 2025, 12:51 IST
- Board meeting
- 21 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE